Influence of using history of immune checkpoint inhibitor therapy for neutropenia caused by combination therapy of ramucirumab and docetaxel

H. Ohno, S. Mano, N. Katagiri, R. Oguri, K. Miyazaki, K. Ito, Y. Sekiya, K. Inoue, A. Masuda, A. Tsuzuku, F. Asano, T. Hirashita, T. Hayashi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Influence of using history of immune checkpoint inhibitor therapy for neutropenia caused by combination therapy of ramucirumab and docetaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences